AstraZeneca Ducks Row Over Too-Broad Patent
A South Carolina federal judge freed AstraZeneca Pharmaceuticals LP from a medical school's patent infringement suit Friday over cholesterol drug Crestor, finding a university scientist's patent unenforceable because it was broad...To view the full article, register now.
Already a subscriber? Click here to view full article